What is "brivaracetam"

n. The 4-n-propyl analogue of levetiracetam, a racetam derivative with anticonvulsant properties, believed to act by binding to the ubiquitous synaptic vesicle protein SV2.

Brivaracetam (trade name Briviact), a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties. It is marketed by the pharmaceutical company UCB.